HCA Healthcare EVP Michael Schlosser sells $593,582 in stock
Michael J. Schlosser, HCA Healthcare's Executive Vice President and Chief Clinical Officer, sold 1,200 shares of the company's stock on November 4, 2026, for a total of $593,582. The shares were sold at prices between $494.63 and $494.70, with a weighted average price of $494.6524 per share. Following the sale, Schlosser owned 1,443.1027 shares directly and indirectly held 6,951 shares through a 2022 Trust.
HCA Healthcare, valued at $106 billion with a P/E ratio of 16.36, appeared undervalued according to InvestingPro analysis. The company reported strong third-quarter 2026 results, exceeding earnings expectations and generating revenue above forecasts. However, HCA healthcare noted a $400 million unfavorable impact on adjusted EBITDA due to a shift in the payer mix.
Despite the strong performance, management indicated consistent 2027 earnings, potentially dampening investor enthusiasm. BofA Securities raised the price target for HCA Healthcare from $450 to $500, citing benefits from supplemental Medicaid programs and solid execution.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
